FI890116A - Icke-reverterande rna-virus. - Google Patents

Icke-reverterande rna-virus. Download PDF

Info

Publication number
FI890116A
FI890116A FI890116A FI890116A FI890116A FI 890116 A FI890116 A FI 890116A FI 890116 A FI890116 A FI 890116A FI 890116 A FI890116 A FI 890116A FI 890116 A FI890116 A FI 890116A
Authority
FI
Finland
Prior art keywords
reverterande
icke
rna virus
vaccines
relates
Prior art date
Application number
FI890116A
Other languages
English (en)
Other versions
FI890116A0 (fi
Inventor
Carolyn Louise Weeks-Levy
Steven Joseph Mento
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of FI890116A0 publication Critical patent/FI890116A0/fi
Publication of FI890116A publication Critical patent/FI890116A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Physical Deposition Of Substances That Are Components Of Semiconductor Devices (AREA)
FI890116A 1988-01-11 1989-01-10 Icke-reverterande rna-virus. FI890116A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14250788A 1988-01-11 1988-01-11

Publications (2)

Publication Number Publication Date
FI890116A0 FI890116A0 (fi) 1989-01-10
FI890116A true FI890116A (fi) 1989-07-12

Family

ID=22500099

Family Applications (1)

Application Number Title Priority Date Filing Date
FI890116A FI890116A (fi) 1988-01-11 1989-01-10 Icke-reverterande rna-virus.

Country Status (9)

Country Link
EP (1) EP0325768B1 (fi)
JP (1) JPH01222774A (fi)
AT (1) ATE121779T1 (fi)
AU (1) AU2833789A (fi)
DE (1) DE3853672T2 (fi)
DK (1) DK8789A (fi)
ES (1) ES2070846T3 (fi)
FI (1) FI890116A (fi)
IL (1) IL88731A0 (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286640A (en) * 1988-01-05 1994-02-15 Almond Jeffrey W Attenuated polioviruses
GB8901093D0 (en) * 1989-01-18 1989-03-15 Almond Jeffrey W Attenuated viruses
US5298416A (en) * 1989-01-18 1994-03-29 British Technology Group Ltd. Attenuated polioviruses
EP0401421B1 (en) * 1989-06-08 1996-01-03 American Cyanamid Company Non-reverting RNA viruses
GB9107563D0 (en) * 1991-04-10 1991-05-29 Macadam Andrew J Thermostable viruses
GB9107552D0 (en) * 1991-04-10 1991-05-29 Macadam Andrew J Attenuated viruses
GB9705669D0 (en) * 1997-03-19 1997-05-07 British Tech Group Attenuated polioviruses
US6853093B2 (en) 2002-12-20 2005-02-08 Lipman Electronic Engineering Ltd. Anti-tampering enclosure for electronic circuitry
US8405506B2 (en) 2010-08-02 2013-03-26 Verifone, Inc. Secure data entry device
US8593824B2 (en) 2010-10-27 2013-11-26 Verifone, Inc. Tamper secure circuitry especially for point of sale terminal

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4719177A (en) * 1981-04-20 1988-01-12 Massachusetts Institute Of Technology Production of complementary DNA representing RNA viral sequences by recombinant DNA methods and uses therefor
JPS59173084A (ja) * 1982-11-30 1984-09-29 インステイチユ−ト・パスツ−ル ポリオウイルスの免疫原性部位よりなるペプチド類及びこれらのペプチド類を暗合化するヌクレオチド配列を含有するｄｎａ類
EP0156299A3 (en) * 1984-03-26 1987-04-01 Chiron Corporation Ltr modified viral vaccines

Also Published As

Publication number Publication date
DE3853672D1 (de) 1995-06-01
DE3853672T2 (de) 1996-01-11
EP0325768A2 (en) 1989-08-02
EP0325768B1 (en) 1995-04-26
EP0325768A3 (en) 1989-08-30
DK8789A (da) 1989-07-12
JPH01222774A (ja) 1989-09-06
IL88731A0 (en) 1989-07-31
AU2833789A (en) 1989-07-13
DK8789D0 (da) 1989-01-10
ES2070846T3 (es) 1995-06-16
FI890116A0 (fi) 1989-01-10
ATE121779T1 (de) 1995-05-15

Similar Documents

Publication Publication Date Title
ATE236262T1 (de) Rekombinanter schweinepocken-virus
LU91152I2 (fr) étanique, d'anatoxine coquelucheuse, d'hémagglutinCombinaison d'anatoxine diphtérique, d'anatoxine tine filamenteuse, de pertactine et de virus poliomyélitique inactivé type 1, type 2 et type 3.
PT83434B (pt) Processo de preparacao de virus recombinantes, de peptidos ou proteinas e de vacinas contra o sindroma de imunodeficiencia adquirida
ATE129160T1 (de) Herpes-simplex-impfstoff, der hsv-glycoprotein-gd und 3-deacyl monophosphoryl-lipid-a enthaelt.
DK0386734T3 (da) Immunogene regioner på E-7-proteinet af humant papillomavirus type 16
DE3789399D1 (de) Herstellung von Vakkzinen gegen Hepatitis B-Virus.
ATE141946T1 (de) Hiv-2-virusvarianten
DE3650289D1 (de) Spike-protein des virus der infektiösen bronchitis.
DE3885431D1 (de) Expression der viral kodierten Protease P2A des HRV2.
NO159274C (no) Analogifremgangsmaate for fremstilling av fenyl-alifatisk-isoksazoler for bekjempelse av virus.
NZ219002A (en) Method of modifying plant virus by pre-transforming plant genome
FI890116A0 (fi) Icke-reverterande rna-virus.
AR242057A1 (es) Poliovirus quimerico viable, cdna recombinante hibrido apto para su produccion en un cultivo de celulas, y procedimiento para la obtencion de dicho poliovirus.
KR930702527A (ko) gp160의 유도체 및 보조약을 함유하는 gp160 또는 그의 유도체를 기재로하는 백신
NO880935L (no) Fremgangmsaate for paavisning av hiv eller annet virus med lignende klinisk virkning.
CY2008005I2 (el) Εμβολιο κατα της παρωτιτιδας που περιεχει στελεχος ιου jeryl-lynn
FI893346A (fi) Icke-reverterande rna-virus.
ATE109007T1 (de) Zellfreies marekskrankheitvirus-vakzin.
FR2671974B1 (fi)
NO891355D0 (no) Vaksinasjon mot rabis-beslektede virus.
DE69014100D1 (de) Cdns des orsv-virus gens.

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: AMERICAN CYANAMID COMPANY